Truemors
is reporting from
Member
NP Rank:
NP Rank:
Drug giants unite to develop cancer therapy
Merck and AstraZeneca, two giant drug houses have announced plans to collaborate on a cancer drug therapy. They are both working on drugs that block a cancer's pathway to growth but when one way is blocked, the cancer may take another pathway. This collaboration...
created by Barbara McPherson | 22 wks ago | updated 22 wks ago
91 views | 36 recommendations | 2 comments
91 views | 36 recommendations | 2 comments
Medical Madoff: Data Faked in 21 Studies
"Over the past 12 years, anesthesiologist Scott Reuben revolutionized the way physicians provide pain relief to patients undergoing orthopedic surgery for everything from torn ligaments to worn-out hips. Now, the...
created by nukegingrich | 34 wks ago | updated 34 wks ago
579 views | 50 recommendations | 5 comments
579 views | 50 recommendations | 5 comments
Merck and Schering-Plough in $41 Billion Merger
Pharmaceutical giant Merck, known for its Gardasil product, is acquiring Schering-Plough in a $41 billion dollar merger. The overall goal is to compete more closely with Pfizer, which is the largetst pharma... Merck approves use of its HPV vaccine Gardasil in males
Human papillomavirus, or HPV, is an oncogenic virus implicated in causing nearly 100% of all cervical cancer cases, but it does not just target females. It also infects males, and can cause anal, penile, neck...
created by yuls.source | 51 wks ago | updated 51 wks ago
1205 views | 10 recommendations | 4 comments
1205 views | 10 recommendations | 4 comments
Brazil to produce generic AIDS drug
" © AP 2008-09-18 03:43:04 - BRASILIA, Brazil (AP) - Brazil's health minister says Latin America's biggest country will produce an inexpensive generic version of an AIDS drug made by Merck & Co. Jose...Weekly Radio Spin -- Merck's Having Chest Pains
Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, we look at how Barbie celebrates Earth Day, why Freedom's...
created by Center for Media and Democracy | 1 year ago | updated 1 year ago
162 views | 0 recommendations | 0 comments
162 views | 0 recommendations | 0 comments
Weekly Radio Spin -- It Pays to Be Duby-ous
This week, we look at why leaders in China -- and the U.S. -- think more propaganda is better, what happens when journalists wear a PR hat too, and who's joining Blackwater's crowded payroll. In "Six Degrees of...
created by Center for Media and Democracy | 1 year ago | updated 1 year ago
191 views | 0 recommendations | 0 comments
191 views | 0 recommendations | 0 comments
Merck tells AIDS vaccine volunteers who got jab
"WASHINGTON (Reuters) - Thousands of people who volunteered to test an experimental AIDS vaccine that may have actually raised the risk of infection will be told if they got the actual shot, researchers said on Tuesday. Merck & Co. Inc. and academic researchers said they...Breaking: Merck Agrees to Pay $4.85 Billion for Vioxx Claims
Merck Agrees to Pay $4.85 Billion for Vioxx ClaimsThree years after withdrawing its pain medication Vioxx from the market, Merck announced today that it will pay $4.85 billion to settle 27,000 lawsuits by people...
created by johnegger23 | 2 years ago | updated 2 years ago
371 views | 0 recommendations | 0 comments
371 views | 0 recommendations | 0 comments
The Politics and PR of Cervical Cancer
The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,...
created by Karen Hatter | 2 years ago | updated 1 year ago
4166 views | 25 recommendations | 7 comments
4166 views | 25 recommendations | 7 comments
Mylan completes acquisition of generics business of Merck KGaA
"Robert J. Coury, Mylan's Vice Chairman and Chief Executive Officer said, "The new Mylan now has all of the critical attributes we need to ensure future success and deliver powerful growth. We have enhanced scale and stability, a truly global reach, vertical and horizontal... HIV Vaccine Fails - Another Clinical Trial on Horizon?
A new HIV vaccine, supported by WHO and UNAIDS, being pushed by Merck hit a roadblock this week. The STEP program, which has participants in North America, Australia, South America, and the Caribbean, has,...
created by ScienceDave | 2 years ago | updated 2 years ago
338 views | 12 recommendations | 3 comments
338 views | 12 recommendations | 3 comments
Vioxx Ruling Eases Threat to Merck
"September 7, 2007 DOW JONES REPRINTS This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order...Schering-Plough Profit up 55%
Schering - Plough's leading drugs for cholestrol fighters rose 21% over a year to fuel record setting earnings for the company. The best sellers are co-marketed with Merck."posted a 55 percent rise in first-quarter earnings, beating analysts' estimates on sharply higher sales...
Recent Comments
Top Members Today
Top Rookies
Top Veterans
58
pointsJenn06188
Absecon, United States- 30
pointsgenelia
kolkata, India 
30
pointskielnhofer
Linz, Austria
